BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20662075)

  • 21. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
    Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
    Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The interphase fluorescence in situ hybridization (I-FISH) technique in patients with chronic lymphatic leukemia (CLL)].
    Michalová K; Zemanová Z; Cmunt E; Karban J; Brezinová J; Sindelárová L; Kurková S; Kubcová S; Schwarz J
    Cas Lek Cesk; 2000 Jun; 139(11):334-8. PubMed ID: 10953412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900).
    Vance GH; Kim H; Hicks GA; Cherry AM; Higgins R; Hulshizer RL; Tallman MS; Fernandez HF; Dewald GW
    Leuk Res; 2007 May; 31(5):605-9. PubMed ID: 16996130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome.
    Kang WY; Shen KN; Duan MH; Zhang W; Cao XX; Zhou DB; Li J
    Eur J Haematol; 2013 Dec; 91(6):490-6. PubMed ID: 23957213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
    Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
    Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
    Koren-Michowitz M; Hardan I; Berghoff J; Yshoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
    Cancer Lett; 2007 Oct; 255(2):307-14. PubMed ID: 17590504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
    Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
    J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of chromosomal abnormalities using fluorescence in situ hybridization (FISH).
    Jobanputra V; Kriplani A; Choudhry VP; Kucheria K
    Natl Med J India; 1998; 11(6):259-63. PubMed ID: 10083791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid prenatal diagnosis of chromosome aneuploidies by interphase fluorescence in situ hybridization: a one-year clinical experience with high-risk and urgent fetal and postnatal samples.
    Bryndorf T; Lundsteen C; Lamb A; Christensen B; Philip J
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):8-14. PubMed ID: 10646809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of assessment of plasma cells by flow cytometry and detection of cytogenomic abnormalities by fluorescence in situ hybridization in plasma cell neoplasms.
    Lu G; Zhang XX; You MJ; Chen W
    Int J Lab Hematol; 2011 Oct; 33(5):545-50. PubMed ID: 21470373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma.
    Flactif M; Zandecki M; Laï JL; Bernardi F; Obein V; Bauters F; Facon T
    Leukemia; 1995 Dec; 9(12):2109-14. PubMed ID: 8609724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells.
    Ortega V; Mohamed G; Ehman W; Zhu M; Mendiola C; Velagaleti G
    Cancer Genet; 2016 Mar; 209(3):82-6. PubMed ID: 26797313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].
    Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation.
    Dascalescu CM; Callanan M; Chauvet M; Le Baccon P; Pégourié-Bandelier B; Garban F; Sotto JJ; Leroux D
    Bone Marrow Transplant; 1999 Apr; 23(7):687-94. PubMed ID: 10218845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
    Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.
    Ng MH; Kan A; Chung YF; Wong IH; Lo KW; Wickham NW; Lei KI; Lee JC
    Am J Pathol; 1999 Jan; 154(1):15-22. PubMed ID: 9916913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma].
    Smejkalová J; Vranová V; Oltová A; Kuglík P; Filková H; Heinigová J; Kovárová L; Adam Z; Krejcí M; Pour L; Büchler T; Svobodník A; Vostrejsová S; Kalábová V; Vorlícek J; Penka M; Hájek R
    Cas Lek Cesk; 2005; 144(7):483-8. PubMed ID: 16161543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis.
    Hardan I; Rothman R; Gelibter A; Cohen N; Shimoni A; Sokolovsky M; Reichart M; Ishoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
    Exp Hematol; 2004 Mar; 32(3):254-60. PubMed ID: 15003310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.